CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-02 | Houston John G President and CEO | Sale | −7,600 | $98.86 | $751K | 833,830 |
| 2021-08-02 | Houston John G President and CEO | Sale | −3,441 | $99.96 | $344K | 830,389 |
| 2021-08-02 | Houston John G President and CEO | Sale | −2,746 | $100.66 | $276K | 827,643 |
| 2021-08-02 | Houston John G President and CEO | Exercise or conversion · Stock Option (right to buy) | −45,922 | 42,228 | ||
| 2021-07-28 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +17,242 | $16.00 | $276K | 175,491 |
| 2021-07-28 | Cassidy Sean A Chief Financial Officer | Sale | −17,242 | $100.00 | $1.7M | 158,249 |
| 2021-07-28 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −17,242 | 29,384 | ||
| 2021-06-30 | Peck Ronald Chief Medical Officer | Exercise or conversion | +20,000 | $47.38 | $948K | 22,754 |
| 2021-06-30 | Peck Ronald Chief Medical Officer | Sale | −20,000 | $76.69 | $1.5M | 2,754 |
| 2021-06-30 | Peck Ronald Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | 55,000 | ||
| 2021-06-10 | Houston John G President and CEO | Exercise or conversion | +43,886 | $16.00 | $702K | 871,529 |
| 2021-06-10 | Houston John G President and CEO | Sale | −17,615 | $80.52 | $1.4M | 853,914 |
| 2021-06-10 | Houston John G President and CEO | Sale | −11,784 | $81.75 | $963K | 842,130 |
| 2021-06-10 | Houston John G President and CEO | Sale | −14,487 | $82.46 | $1.2M | 827,643 |
| 2021-06-10 | Houston John G President and CEO | Exercise or conversion · Stock Option (right to buy) | −43,886 | 42,734 | ||
| 2021-06-09 | Houston John G President and CEO | Exercise or conversion | +700 | $16.00 | $11K | 828,343 |
| 2021-06-09 | Houston John G President and CEO | Sale | −700 | $80.15 | $56K | 827,643 |
| 2021-06-09 | Houston John G President and CEO | Exercise or conversion · Stock Option (right to buy) | −700 | 86,620 | ||
| 2021-06-08 | Smaldone Alsup Laurie Director | Grant or award · Stock Option (right to buy) | +7,511 | 7,511 | ||
| 2021-06-08 | Ratcliffe Liam Director | Grant or award · Stock Option (right to buy) | +7,511 | 7,511 |
Page 18 of 32 · 628 trades